- Home
- HSCS vs IDAI Comparison
HSCS vs IDAI Comparison
Compare HSCS & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSCS | IDAI |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 13.0M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HSCS | IDAI |
|---|---|---|
| Price | $3.44 | $2.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $8.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 136.9K | 40.2K |
| Earning Date | 03-16-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.84 | ★ 76.50 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,319.00 | N/A |
| Revenue This Year | N/A | $103.06 |
| Revenue Next Year | N/A | $140.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.63 | $1.17 |
| 52 Week High | $4.35 | $5.28 |
Technical Indicators
Market Signals| Indicator | HSCS | IDAI |
|---|---|---|
| Relative Strength Index (RSI) | 57.75 | 53.75 |
| Support Level | $1.88 | $2.31 |
| Resistance Level | $3.57 | $3.51 |
| Average True Range (ATR) | 0.35 | 0.22 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 39.01 | 25.45 |
Price Performance
Historical ComparisonAbout HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The company operates in one reportable segment, artificial intelligence-powered solutions. The artificial intelligence-powered solutions segment generates revenue from software licenses, professional services, and recurring SaaS revenue.